Steven M. Devine, MD

Comprehensive Cancer Center, The Ohio State University, Columbus, OH

John F. DiPersio, MD, PhD

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Gowthami M Arepally, MD

Medicine, Division of Hematology, Duke University Med. Ctr., Durham, NC

Kenneth I. Ataga, MD

Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC

Catherine M. Bollard, MD

Children's National Hospital, Washington, DC; The George Washington University, Washington, DC

Robert C. Flaumenhaft, MD, PhD

Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA

Solveig G. Ericson, MD, PhD

Novartis Pharmaceuticals, East Hanover, NJ

Jeffery L. Kutok, MD, PhD

780 Memorial Drive, Infinity Pharmaceuticals, Inc., Cambridge, MA

Nicole J. Gormley, MD

Office of Oncology Drug Products, Federal Drug Administration, Silver Spring, MD

Louis M. Staudt, MD, PhD

National Cancer Institute, Bethesda, MD

Staci D. Arnold, MD, MBA

Columbia University Medical Center, Morgan Stanley Children's Hospital of New York- Presbyterian, New York, NY

Smita Bhatia, MD, MPH

Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL

John Crispino, PhD

Medicine, Hematology/Oncology, Northwestern University, Chicago, IL

Barbara C. Furie, PhD

Beth Israel Deaconess Med. Ctr., Boston, MA

Emmanuelle Passegue, PhD

The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California - San Francisco, San Francisco, CA

Michael Lankiewicz, MD

Christiana Care Health System, Newark, DE

Leslie S. Kersun, MD

Children's Hospital of Philadelphia, Philadelphia, PA

Alexandra Wolanskyj, MD

Mayo Clinic Mayo Building West 10, Rochester, MN

Lawrence T Goodnough, MD

Pathology and Medicine, Stanford University, Stanford, CA